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Nucleotide-binding, oligomerization domain (NOD)-like receptor (NLR) proteins are a family of innate immune
receptors that play a pivotal role in microbial sensing, leading to the initiation of antimicrobial immune
responses. Dysregulation of the function of multiple NLR family members has been linked, both in mice
and humans, to a propensity for infection and autoinflammatory disease. Despite our increased under-
standing of NLR function and interactions, many aspects related to mechanisms of sensing, downstream
signaling, and in vivo functions remain elusive. In this review, we focus on key members of the NLR family,
describing their activation by diverse microbes, downstream effector functions, and interactions with each
other and with other innate sensor protein families. Also discussed is the role of microbial sensing by NLR
receptors leading to activation of the adaptive immune arm that collaborates in the antimicrobial defense.Introduction
Nucleotide-binding, oligomerization domain-like receptor (NLR)
proteins are a family of proteins with diverse functions in the
immune system, characterized by a shared domain architecture
that includes a nucleotide-binding domain (NBD) and a leucine-
rich repeat (LRR) domain. The latter, which is shared with other
innate immune proteins such as the Toll-like receptor (TLR)
family, is thought to play a role in recognition and autoregulation
of pathogen- and danger-associatedmolecular patterns (PAMPs
and DAMPs, respectively). The NBD can bind nucleotides and is
possibly involved in the induction of conformational changes and
self-oligomerization that are necessary for NLR function. On the
basis of the presence of additional domains, NLRswere grouped
into subfamilies (Table 1) (Ting et al., 2008). Typical domains
present in NLRs are the caspase activation and recruitment
domains (CARDs) and the pyrin domains (PYDs). These domains
are involved in homeotypic protein interactions and allow the
recruitment of downstream effector molecules.
In this review, wewill highlight the function of several members
of the NLR family that are involved in the regulation of the antimi-
crobial immune response and focus on concepts of pathogen
recognition as well as their interplay with other innate immune
receptors.
NOD1 and NOD2
Two widely studied members of the NLRC (NOD-like receptor
containing a CARD domain) family are NOD1 and NOD2. The
discovery that mutations in NOD2 are strongly associated with
Crohn’s disease, an autoinflammatory disorder that is thought
to be driven by aberrant immune response against intestinal
microbes (reviewed in Cho, 2008), highlighted the importance
of NLRs in the regulation of antimicrobial responses. NOD1
and NOD2 are cytosolic receptors that recognize distinct
building blocks of peptidoglycan (PGN), a polymer consisting
of glycan chains crosslinked to each other via short peptides
(Fritz et al., 2006). In Gram-positive bacteria, it is the majorbuilding block of the cell wall. Although it is present only in
smaller amounts in Gram-negative bacteria, its general abun-
dance and its highly conserved structure make PGN a prime
target for recognition by pattern recognition receptors (PRRs).
NOD2 recognizes a minimal motif of muramyl dipeptide (MDP)
that is found in all PGNs. In contrast, NOD1 recognizes muro-
peptides (iE-DAPs) that are found in the PGN of Gram-negative
and only some Gram-positive bacteria (Figure 1). Because
PGN structures are actively remodeled during bacterial cell
growth and division, the constant release of NOD1 and NOD2
ligands from bacteria allows the innate immune system to survey
its surrounding for the presence of bacteria. Interestingly, recent
studies have identified additional agonists for NOD2, N-glycolyl
muramyl dipeptide from mycobacteria (Coulombe et al., 2009)
and viral ssRNA (Sabbah et al., 2009) (discussed below) demon-
strating that NOD1 and NOD2 initiate innate responses upon
recognition of a larger variety of pathogen-derived molecules.
The mechanisms by which these agonists cross the host’s cell
membrane to stimulate NOD1 and NOD2 remain not fully under-
stood. This is important given that only a minority of bacteria
replicates in the cytoplasm, where they can be directly sensed,
yet bacteria localized in phagosomes and outside the cell can
effectively activate both NOD1 and NOD2. Several transport
systems, including pannexin, PepT1, and PepT2, as well as
endocytosis, have been demonstrated to enable hydrophilic
muramyl peptides to cross to the cytoplasm (Lee et al., 2009;
Marina-Garcı´a et al., 2009; Vavricka et al., 2004).
Signaling downstream of NOD1 and NOD2 was thought to
mainly result in the activation of NF-kB signaling (Fritz et al.,
2006; Kanneganti et al., 2007) (Figure 1). Indeed, recognition of
PGN ligands by NOD1 and NOD2 leads to a conformational
change that activates receptor-interacting serine-threonine
kinase 2 (RIP2) via cellular inhibitors of apoptosis 1 and 2
(cIAP1 and 2) (Bertrand et al., 2009), subsequently leading to
ubiquitination of NF-kB essential modulator (NEMO) and the
activation of the proinflammatory NF-kB pathway. In parallel,Immunity 34, May 27, 2011 ª2011 Elsevier Inc. 665
Table 1. The NLR Family
Subfamily Human Mouse N Terminus Other Names
NLRA
CIITA CARD NLRA;MHCIITA;C2TA
CIIta CARD Nlra; MHCIITA;C2ta
NLRB
NAIP BIR BIRC1;CLR5.1
Naip1-7 BIR Birc1a-g
NLRC
NOD1 CARD NLRC1;CARD4;CLR7.1
Nod1 CARD Nlrc1;Card4
NOD2 CARD NLRC2;CARD15;CD;BLAU;IBD1;PSORAS1; CLR16.3
Nod2 CARD Nlrc2;Card15
NLRC3 CARDa NOD3;CLR16.2
Nlrc3 CARDa Clr16.2
NLRC4 CARD IPAF;CARD12;CLAN;CLR2.1
Nlrc4 CARD Ipaf;Card12;CLAN
NLRC5 CARDa NOD27;NOD4;CLR16.1
Nlrc5 CARDa
NLRP
NLRP1 PYD NALP1;CARD7;NAC;DEFCAP;CLR17.1
Nlrp1a-c PYD Nalp1a-c
NLRP2 PYD NALP2;PYPAF2;NBS1;PAN1;CLR19.9
Nlrp2 PYD Nalp2;Pypaf2;Nbs1;Pan1
NLRP3 PYD NALP3;Cryopyrin;CIAS1;PYPAF1;CLR1.1
Nlrp3 PYD Nalp3;Cryopyrin;Cias1;Pypaf1;Mmig1
NLRP4 PYD NALP4;PYPAF4;PAN2;RNH2;CLR19.5
Nlrp4a PYD Nalp4a;Nalp-eta;Nalp0D
Nlrp4b PYD Nalp4b;Nalp-gamma;Nalp9E
Nlrp4c PYD Nalp4c;Nalp-alpha;RNH2
Nlrp4d PYD Nalp4d;Nalp-beta
Nlrp4e PYD Nalp4e;Nalp-epsilon
Nlrp4f PYD Nalp4f;Nalp-kappa;Nalp9F
Nlrp4g PYD Nalp4g
NLRP5 PYD NALP5;PYPAF8;MATER;PAN11;CLR19.8
Nlrp5 PYD Mater;Op1
NLRP6 PYD NALP6;PYPAF5;PAN3;CLR11.4
Nlrp6 PYD Nalp6
NLRP7 PYD NALP7;PYPAF3;NOD12;PAN7;CLR19.4
NLRP8 PYD NALP8;PAN4;NOD16;CLR19.2
NLRP9 PYD NALP9;NOD6;PAN12;CLR19.1
Nlrp9a PYD Nalp9a;Nalp-theta
Nlrp9b PYD Nalp9b;Nalp-delta
Nlrp9c PYD Nalp9c;Nalp-zeta
NLRP10 PYD NALP10;PAN5;NOD8;PYNOD;CLR11.1
Nlrp10 PYD Nalp10;Pynod
NLRP11 PYD NALP11;PYPAF6;NOD17;PAN10;CLR19.6
PYD
NLRP12 PYD NALP12;PYPAF7;Monarch1;RNOS;PAN6;CLR19.3
Nlrp12 PYD Nalp12
NLRP13 PYD NALP13;NOD14;PAN13;CLR19.7
PYD
666 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.
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Table 1. Continued
Subfamily Human Mouse N Terminus Other Names
NLRP14 PYD NALP14;NOD5;PAN8;CLR11.2
Nlrp14 PYD Nalp14;Nalp-iota;GC-LRR
NLRX1
NLRX1 CARDa NOD9;CLR11.3
Nlrx1 CARDa
This table is adapted from Kanneganti et al. (2006) and Bryant and Fitzgerald (2009).
aCurrently disputed as to whether it contains a CARD, PYD, or another N terminus binding domain.
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activated protein kinase (MAPK) pathway via RIP2, which con-
tributes to cytokine production. Importantly, numerous studies
have highlighted the interaction with other signaling pathways
that stimulate NF-kB, including TLRs (Lee and Kim, 2007).
Depending on the cell type, NOD agonists modulate the magni-
tude of TLR ligand-induced cytokine production. In dendritic
cells, NOD1 and NOD2 agonists can synergize with TLR ligands
leading to enhanced production of proinflammatory cytokines
(Fritz et al., 2005). In contrast, in splenocytes MDP treatment
leads to a hyporesponsive state and decreased TLR ligand-
induced NF-kB signaling (Watanabe et al., 2004), indicating
that the interaction between the different PRR pathways is
strongly dependent on the cellular context as well as the inflam-
matory setting.
Both NOD1 and NOD2 are highly expressed in antigen-
presenting cells (APCs) such as monocytes, macrophages, and
dendritic cells (Fritz et al., 2006; Kanneganti et al., 2007). Several
recent studies identified NOD2 expression also in other hemato-
poietic lineages (Petterson et al., 2011; Shaw et al., 2009). In
addition, NOD1 is expressed in many epithelial cell subsets,
whereas NOD2 seems to be more restricted to specialized cell
types such as Paneth cells in the small intestine. NOD2 expres-
sion is potently induced by TLR ligands including LPS and by
inflammatory mediators such as TNF-a, IFN-g, and IL-17 in other
nonhematopoietic tissues. Furthermore, a recent study demon-
strated that NOD2 expression in the intestine is regulated by
signals from the microbiota, given that germfree mice had lower
NOD2 expression that was reversible upon monocolonization
with commensal bacteria (Petnicki-Ocwieja et al., 2009).
Role of NOD1 in the Antimicrobial Response
A role for NOD1 as a modulator of the in vivo antimicrobial
response was described first in infection with the pathogen
Helicobacter pylori, in which Nod1/ mice featured enhanced
susceptibility to infection with this pathogen (Viala et al., 2004).
This phenotype correlated with an impaired acute inflammatory
response, probably due to decreased production of chemokines
bygastric epithelial cells aswell as to impaired innate immunecell
recruitment. Subsequent studies established roles for NOD1 in
the induction of cytokines, antimicrobial peptides, and type I
interferons during H. pylori infection (Watanabe et al., 2010a). In
the later study, Strober and colleagues found an unexpected
signaling pathway in epithelial cells leading to the induction of
IFN-b via RIP2 and TNF-receptor-associated factor 3 (TRAF3)
(Watanabe et al., 2010b). NOD2-mediated immune control of
the infection further required members of the canonical type Iinterferon cascade consisting of IFN-regulatory factor 7 (IRF7),
and the IFN-stimulated gene factor 3 (ISGF3) complex. Similar
to studies with TLR-deficient mice, Nod1/ mice also had
reduced T helper 1 (Th1) cell responses upon H. pylori infection,
suggesting that the twopathwaysmay cooperate in the induction
of adaptive immune responses.
NOD1 has also been involved in the recognition of other patho-
gens including Clostridium difficile (Hasegawa et al., 2011),
Legionella pneumophila (Berrington et al., 2010a; Frutuoso et al.,
2010), Listeria monocytogenes (Boneca et al., 2007), Staphylo-
coccus aureus (Travassos et al., 2004), and Pseudomonas
aeruginosa (Travassos et al., 2005). In many of these studies,
either an impaired recruitmentor functionofneutrophilswasnoted
during the inflammatory process. An interesting finding was re-
ported, in which impaired neutrophil function in Nod1/ mice
was observed already in the steady state that could have con-
tributed to the results of the other studies (Clarke et al., 2010). It
was hypothesized that PGNs derived from commensal bacteria
circulating in the serum prime neutrophils at distant sites through
NOD1 signaling. Accordingly, broad-spectrum antibiotic-treat-
ment that leads to suppression of certain commensal microflora
communities resulted in similarly diminished neutrophil-mediated
antimicrobial responses, whereas injection of NOD1 ligands was
able to restore the normal response.
NOD1 was also demonstrated to provide protection against
infection with the intracellular parasite Trypanosome cruzi, the
etiological agent of Chagas disease (Silva et al., 2010). Nod1/
mice featured worsened disease, normal production of cyto-
kines, and levels of parasitemia similar to those of Myd88/
mice, which, in turn, featured a near complete lack of cytokine
induction. The exacerbated disease in Nod1/ mice was
suggested to be the result of impaired ability of macrophages
to kill intracellular parasites. These results indicate that, in
some infections, TLRs and NOD1 may orchestrate different
aspects of the immune response upon infection. Additional
in vivo studies will be needed to understand the role of NOD1
during systemic immune responses, whichmay lead to new ther-
apeutic approaches.
Role of NOD2 in the Antimicrobial Response
In vitro studies have implicated NOD2 in a number of bacterial
infectious models including Listeria monocytogenes (Kobayashi
et al., 2005), Staphylococcus aureus (Deshmukh et al., 2009),
Chlamydophila pneumoniae (Shimada et al., 2009), Strepto-
coccus pneumoniae (Opitz et al., 2004), and Mycobacterium
tuberculosis (Divangahi et al., 2008). Interestingly, NOD2 was
found to be required for immune control of L. monocytogenesImmunity 34, May 27, 2011 ª2011 Elsevier Inc. 667
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Figure 1. Microbial Activation of NLRs
(A) Activation of NOD1 and NOD2 results, depending on the recognized ligand, in transcription of genes encoding chemokines, cytokines, antimicrobial peptides,
and type I interferons. MDPs and iE-DAPs are derived from extracellular, intracytosolic, or intravesicular bacteria, whose recognition can stimulate activation of
the NF-kB and MAPK pathways. NOD1-mediated recognition of H. pylori and NOD2-mediated recognition of ssRNA stimulate type I interferon transcription via
IRF7 and IRF3, respectively. NOD1 and NOD2 recruit ATG16L to sites of bacterial phagocytosis to initiate autophagy.
(B) Activation of NLRC4 and NLRP3 results in assembly of inflammasomes that activate caspase-1. This activation requires two signals. Signal I induces
transcription of pro-IL-1b and pro-IL-18; signal II is provided by PAMPs and DAMPs. In the case of NLRC4, recognition of cytoplasmatic flagellin leads to
pyropotosis, a specialized form of cell death, via an ASC-independent mechanism. NLRC4 also induces processing of pro-IL-1b and pro-IL-18 via ASC-
dependent mechanisms. NLRP3 senses either directly microbial molecules or indirectly signals associated with cellular perturbations such as increased ROS
production, release of lysosomal proteases into the cytoplasm upon ‘‘frustrated’’ phagocytosis, and potassium efflux. Assembly of the NLRP3 inflammasome
leads to processing of pro-IL-1b and pro-IL-18 by caspase-1.
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cating that NOD2 might have nonredundant functions in intes-
tinal antimicrobial responses, whereas other PRRs such as
TLRs could be sufficient for the host antimicrobial response
when infected via different routes. A recent study highlighted
collaboration between NOD1 and NOD2 in the Salmonella typhi-
murium colitis model (Geddes et al., 2010). Although mice defi-
cient in either NOD1 or NOD2 had normal susceptibility for infec-
tion, mice deficient in both NOD1 and NOD2 featured decreased
inflammation but increased bacterial colonization of the intes-
tine. Notably, NOD1 and NOD2 expression in both hematopoi-
etic and nonhematopoietic cells contributed to resistance
against infection. Although this was in an apparent conflict with
a previous study demonstrating thatRipk2/mice have compa-
rable disease to wild-type (WT) controls (Bruno et al., 2009), the
authors found that RIP2 (encoded by Ripk2) was only involved in
S. typhimurium-induced colitis with bacteria expressing prefer-
entially a particular type III secretion system (Salmonella patho-
genicity island [SPI]-2). This suggests that pathogen-sensing
requirements are not only distinct for different microbes, but
may differ among subtypes within the same species.668 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.The traditional view that NOD2 only recognizes MDP was
recently challenged as Nod2/ cells were found to be impaired
in the expression of type I interferons upon stimulation with viral
single-stranded RNA (ssRNA)(Sabbah et al., 2009). Interestingly,
this pathway is independent of RIP2 and does not require the
CARD domain, but is rather dependent on the mitochondrial
antiviral signaling protein (MAVS) and interferon regulatory factor
3 (IRF3) (Figure 1). Strikingly, Nod2/ mice have an enhanced
susceptibility to infection with respiratory syncytial virus (RSV)
and decreased production of IFN-b after influenza virus infection
(Figure 2). The authors were able to demonstrate direct binding
of NOD2 to viral ssRNA, but not host mRNA, by PCR methods.
Therefore, NOD2 has the ability to recognize a larger variety of
structural elements than previously appreciated.
Induction of Autophagy by NOD1 and NOD2
Autophagy is a lysosomal degradation pathway that was origi-
nally shown to be important during development and in meta-
bolic states of stress such as starvation, but was subsequently
demonstrated to be central in antimicrobial immunity (Mu¨nz,
2009). Recently, it has been reported that NOD1 and NOD2 are
BA
Figure 2. Crosstalk between NLRs and Other Innate Immune Pathways
(A) Influenza virus infection. Extracellular PRRs (TLR4) recognizes microbial products, whereas influenza virus is detected by TLR7. This leads to transcriptional
activation of genes encoding proinflammatory cytokines (pro-IL-1b, pro-IL-18, TNF-a, and IL-6) in an NF-kB-dependent manner (signal I). Influenza virusM2 ionic
channel mediates the activation of the NLRP3 inflammasome that leads to pro-IL-1b and pro-IL-18 processing and secretion (signal II). NOD2 recognizes
influenza virus ssRNA stimulating type I interferon transcription via IRF3.
(B) Salmonella infection. Salmonella is recognized by extracellular PRRs (TLR2, TLR4, and TLR5) resulting in transcriptional activation of genes encoding
pro-inflammatory cytokines (pro-IL-1b, pro-IL-18, TNF-a, and IL-6) in an NF-kB-dependent manner (signal I). Intracellular Salmonella activate NLRP3 and NLRC4
inflammasomes, which leads to pro-IL-1b, pro-IL-18 processing into their biological active forms. NLRC4 responds to flagellin injected by the T3SS, whereas
NLRP3 is activated through an undefined T3SS-independent signal (signal II). NLRP3 inflammasome assembly is completely dependent on ASC, whereas NLRC4
may assemble an inflammasome without ASC. NLRC4 inflammasome activation also results in pyroptosis and release of bacteria into the extracellular space.
Activation of NOD1 and NOD2 by Salmonella leads to chemokine secretion and neutrophil recruitment to the site of infection. NOD1 and NOD2 also target
ATG16L to sites of bacterial phagocytosis to initiate autophagy.
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agonists leads to the NOD-dependent recruitment of ATG16L to
the plasma membrane at sites of Salmonella typhimurium and
Shigella flexneri intrusion (Figure 2) (Cooney et al., 2010; Travas-
sos et al., 2010). This recruitment resulted in efficient degrada-
tion of bacteria in autophagosomes and subsequent processing
of bacterial antigens for presentation onMHC class II molecules.
In these studies, conflicting results were reported on RIP2
dependency of this pathway, which could potentially be attrib-
uted, at least partially, to the different model systems (human
versus mouse) and cell types (dendritic cells versus fibroblasts).
Further studies are needed to determine the details of this
pathway. Mutations in NOD2 that are associated with Crohn’s
disease resulted in its impaired abilities to recruit ATG16L to
the plasma membrane, induce autophagy, and promote antigen
presentation. Importantly, this finding was able to link mutations
that have been associated with Crohn’s disease, i.e., NOD2 as
well as ATG16L mutations, into a single pathway (Cho, 2008). Itwill be of extraordinary interest to understand the molecular
details of this pathway, whichmay lead to aberrant bacterial pro-
cessing and defective presentation of antigens to CD4+ T cells,
resulting in an inflammatory cascade characteristic of Crohn’s
disease.
Regulation of the Antimicrobial Adaptive Immune
Response by NOD1 and NOD2
Beyond NOD1 and NOD2’s roles in modulation of innate immu-
nity, they also direct adaptive immune responses. Such effects
were already demonstrated in early studies identifying MDP as
the minimal adjuvant components of complete Freund’s adju-
vant (Strominger, 2007). Indeed, NOD1 and NOD2 were shown
to be directly involved in the priming of adaptive immunity
when cognate ligands were used as adjuvant (Kobayashi et al.,
2005; Werts et al., 2007). Notably, nonhematopoietic cells
required NOD1, indicting an important role for this molecule in
epithelial and stromal cells upstream of APCs (Werts et al.,Immunity 34, May 27, 2011 ª2011 Elsevier Inc. 669
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immune response via APCs and the microenvironment, it was
found to directly act in T cells as part of a modulatory network
that controls the antimicrobial response. There is an enhanced
susceptibility of Nod2/ mice to Toxoplasma gondii infection,
which was attributed to a diminished T cell IFN-g production
(Shaw et al., 2009). This cell-intrinsic effect was suggested to
involve a defect in signaling downstream of the costimulatory
molecule CD28. Studies in other T cell-dependent models,
including graft-versus-host disease (GVHD) (Penack et al.,
2009) and an in vivo Th2 cell model (Magalhaes et al., 2008),
did not report NOD2-dependent intrinsic defects in T cell func-
tion, suggesting that NOD2 functions in a nonredundant manner
in T cells under specific conditions, possibly depending on the
level of CD28 requirement.
Inflammasome Forming NLR Proteins
In contrast to the NOD proteins, several other members of the
NLR protein family (see Table 1) may form multiprotein com-
plexes, named ‘‘inflammasomes.’’ This results in activation of
inflammatory caspases, cysteine proteases that are synthesized
as inactive zymogens. Upon activation, caspases trigger cellular
programs that lead to inflammation or cell death. Caspase-1 is
the most prominent member of the proinflammatory group of
caspases that also includes caspase-4, caspase-5, caspase-11,
and caspase-12. Activation of pro-caspase-1 is essential for the
processing of pro-IL-1b and pro-IL-18 and for the secretion of
their mature active forms. Caspase-1’s catalytic activity is tightly
regulated by the inflammasomes, in a signal-dependent manner.
Inflammasomes require two signals to accomplish their biolog-
ical function. Signal I initiates transcriptional activation of inflam-
masome components and is often provided through TLR and
NF-kBsignaling, whereas signal II is required to initiate inflamma-
some assembly.
Known inflammasomes are composed of one of several NLR
and PYHIN proteins, including NLRP1, NLRP3, NLRC4, and
AIM2 that function as sensors of endogenous or exogenous
PAMPs or DAMPs (Sutterwala et al., 2007b). After sensing the
relevant signal, inflammasomes are assembled through homo-
philic CARD-CARD and PYD-PYD interactions between NLRs,
apoptosis-associated speck-like protein containing a CARD
(ASC), and pro-caspase-1 (Agostini et al., 2004; Martinon
et al., 2002). Inflammasome components and the activation of
downstream pathways depend on the nature of the stimuli, the
sensor protein and, to some extent, on the presence of absence
of ASC. Although there is conclusive evidence that NLRP1,
NLRP3, and NLRC4 regulate proinflammatory responses
through caspase-1 activation, domain structure conservation
through the NLRP family suggests that other uncharacterized
members might also regulate inflammasome assembly.
NLRC4
NLRC4 contains an N-terminal CARD, a central NOD domain,
and a C-terminal LRR. NLRC4 is expressed mainly in lymphoid
tissues, more specifically in myeloid cells, but also in the gastro-
intestinal tract (Hu et al., 2010). Activation of the NLRC4 inflam-
masome leads to caspase-1 activation, release of IL-1b, and
a rapid form of cell death called pyroptosis (Sutterwala and
Flavell, 2009) (Figure 1). Because NLRC4 contains a CARD670 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.domain, it can interact directly with pro-caspase-1; therefore,
the role of ASC in NLRC4-mediated responses has remained
elusive. Infection of ASC-deficient macrophages with NLRC4-
activating bacteria results in defective caspase-1 activation
and IL-1b secretion (Mariathasan et al., 2004; Sutterwala et al.,
2007a; Suzuki et al., 2007), yet normal pyroptosis, suggesting
that pathways downstream NLRC4 are independently regulated
through the presence of ASC. In concordance, Broz and
colleagues demonstrated that NLRC4-Inflammasomes con-
taining ASC form a single large ‘‘focus’’ in which Caspase-1
undergoes autoproteolysis and processes IL-1b /IL-18. In
contrast, NLRC4-ASC-independent inflammasomes activate
Caspase-1 without autoproteolysis and do not form any large
structures in the cytosol. Moreover, Caspase-1 mutants that
were unable to undergo autoproteolysis promoted rapid cell
death and processed IL-1b /IL-18 inefficiently, which suggests
that NLRC4 forms spatially and functionally distinct inflamma-
somes complexes in response to bacterial pathogens (Broz
et al., 2010b). Interestingly, NLRC4 and ASC probably do not
interact directly as NLRC4 does not contain a PYD; therefore,
it is possible that additional PYD-containing proteins are
required for NLRC4-ASC-dependent processing of IL-1b in
response to pathogens.
Bacterial Activation of the NLRC4 Inflammasome
The NLRC4 inflammasome activators are mainly Gram-negative
bacteria that contain bacterial type III (T3SS) or type IV (T4SS)
secretion systems. These include Salmonella (Mariathasan
et al., 2004), Legionella (Zamboni et al., 2006), Shigella (Suzuki
et al., 2007),Pseudomonas (Sutterwala et al., 2007a), andYersinia
(Brodsky et al., 2010). The microbial molecule flagellin is re-
quired to induce NLRC4-mediated caspase-1 activation during
Legionella, Salmonella, and low burden infection of Pseudo-
monas (Franchi et al., 2006; Franchi et al., 2007; Miao et al.,
2006; Miao et al., 2008; Molofsky et al., 2006). L. pneumophila
and S. typhimuriummutant strains lacking flagellin or expressing
point mutations in its gene are defective in their ability to induce
caspase-1 activation (Franchi et al., 2006; Miao et al., 2006).
Moreover, delivery of flagellin molecules to the cytosol through
transfection or retroviral transduction results in caspase-1 activa-
tion in an NLRC4-dependent manner (Franchi et al., 2006; Light-
field et al., 2008; Miao et al., 2006). In contrast, extracellular
flagellin is unable to induce the activation of theNLRC4 inflamma-
some, suggesting that additional factors are required to enable
flagellin transport into the cytosol (Franchi et al., 2006; Miao
et al., 2006). Because NLRC4 activation is dependent on func-
tional bacterial secretion systems (T3SS, T4SS) (Franchi et al.,
2006; Sutterwala et al., 2007a; Suzuki et al., 2007; Zamboni
et al., 2006), it has been proposed that the T3SS can serve as a
route for flagellinmonomers to gain entry into the cytosol, leading
to caspase-1 activation (Sun et al., 2007). L. pneumophila is
unique in that the activation of the NLRC4 inflammasome by the
C-terminalportionof itsflagellin requires thepresenceofasecond
NLRP, NAIP5 (Coers et al., 2007; Zamboni et al., 2006). NLRC4
and NAIP5 had been suggested to physically interact to regulate
caspase-1 activation; however, the exact role of NAIP5 in this
process remains uncertain.
The NLRC4 inflammasome can also be activated in a flagellin-
independent manner. The nonflagellated bacterium S. flexneri
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been shown to activate capase-1 through NLRC4 (Sutterwala
et al., 2007a; Suzuki et al., 2007). These observations suggest
that additional microbial molecules can trigger assembly of the
NLRC4 inflammasome. Indeed, Miao and colleagues recently
demonstrated that NLRC4 detects the rod protein of the T3SS
of multiple Gram-negative bacteria through a sequence motif
that is also found in flagellin (Miao et al., 2010b).
NLRC4 Interaction with Other Proinflammatory
Signaling Pathways
NLRC4 plays a critical role during pulmonary and peritoneal
P. aeruginosa infection (Franchi et al., 2007; Sutterwala et al.,
2007a). However, NLRC4 contribution during other bacterial
infections is less clearly defined, suggesting that it may have
redundant or additive roles during host immune responses.
S. typhimurium-infected NLRC4-deficient macrophages feature
marked defects in caspase-1 activation and pyroptosis (Maria-
thasan et al., 2004). In contrast, in vivo studies suggested that
the absence of caspase-1 but not of NLRC4 results in enhanced
susceptibility to S. typhimurium infection (Lara-Tejero et al.,
2006). The discrepancy between the in vitro and in vivo results
suggests that additional pathways contribute to Salmonella-
induced caspase-1 activation. In fact, although NLRC4 is acti-
vated by Salmonella flagellin, NLRP3 responds to another, unde-
fined, Salmonella-T3SS-independent signal (Figure 2) (Broz
et al., 2010a). Accordingly, mice lacking both NLRs were more
susceptible to S. typhimurium infection (Broz et al., 2010a). Simi-
larly, Yersinia-T3SS triggers ASC-dependent caspase-1 activa-
tion through the NLRP3 and NLRC4 inflammasomes (Brodsky
et al., 2010). Interestingly, NLRP3 was not essential for the
in vivo bacterial clearance in this study (Brodsky et al., 2010).
In vivo restriction of L. pneumophila is dependent on complex
interactions between the MyD88, NOD1 and NOD2, and NLRC4
pathways. Rip2-deficient mice infected with a flagellin-deficient
L. pneumophila (DflaA) were able to clear the bacteria, indicating
that MyD88 signaling, independently of RIP2 and NLRC4, is able
to protect the host against L. pneumophila infection (Archer
et al., 2010). Concurrently, WT and DflaA L. pneumophila grew
to comparable levels in the lung of Myd88/ mice, which
suggests that replication of L. pneumophila was not restricted
severely by the NLRC4 pathway. However, Myd88/ mice
survived a high-dose challenge of WT L. pneumophila but
succumbed to equal doses of DflaA strain; therefore, NLRC4
provides a level of host protection under high bacterial burden
that is independent of MyD88 (Archer et al., 2010). In this
context, signaling through RIP2 and MyD88 cooperate to attract
neutrophils to the site of L .pneumophila infection; this can be of
particular importance in light of recent evidence indicating that
NLRC4-dependent, ASC-independent pyroptosis results in
bacterial release from macrophages, exposing bacteria to
uptake and killing by neutrophils (Miao et al., 2010a).
Finally, a crosstalk between NLRC4 and TLR5 (flagellin-
extracellular receptor) has been recently identified. TLR5 has
a protective role in S. typhimurium and P. aeruginosa infection
in mice (Hawn et al., 2003; Morris et al., 2009). Likewise, humans
carrying a dominant-negative allele of TLR5 are more suscep-
tible to L. pneumophila infection, suggesting that TLR5 and
NLRC4 have nonredundant roles in these infections (Hawnet al., 2003). In contrast, flagellin and OVA immunization elicits
a normal humoral immune response in single Nlrc4/ or Tlr5/
mice but not in Nlrc4/Tlr5/ mice (Vijay-Kumar et al., 2010).
NLRP3
NLRP3, likemost othermembers of the NLRP subfamily (with the
exception of NLRP10), consists of a carboxy-terminal LRR
domain, a central NOD domain, and an amino-terminal PYD,
mainly interacting with ASC (Schroder and Tschopp, 2010).
NLRP3 is mainly expressed in multiple cells of the hematopoietic
system, of the lymphocytic and myelogenic lineages, and in
other cell types such as skin keratinocytes, transitional epithe-
lium of the urinary tract, and osteoblasts. Noninfectious triggers
for NLRP3 inflammasome formation include crystal activators
such as monosodium urate (MSU), calcium pyrophosphate
dihydrate (CPPD), asbestos, silica, and alum, protein aggregates
such as fibrillar b-amyloid, haptens such as trinitrophenylchlor-
ide, and ultraviolet irradiation. A detailed description of these
DAMPs is provided elsewhere (Schroder and Tschopp, 2010).
In general, inflammasome activation is believed to involve two
steps, the first involving transcription of the ‘‘building blocks,’’
e.g., pro- IL-1b, pro-IL-18, and pro-caspase-1, as well as
expression of NLRP3 itself in the case of NLRP3 inflammasome
activation. The second step, through poorly understood interac-
tions of activators with the relevant NLRP, leads to inflamma-
some assembly that in turn drives cleavage and release of active
IL-1b and IL-18. This process is best studied in the NLRP3
inflammasome. The first priming event of NLRP3 inflammasome
activation involves intricate interaction with other PRR such as
TLR and NOD2, resulting in NF-kB-driven transcriptional activa-
tion. TLR-induced priming can be performed through both the
MyD88 and TRIF pathways, given that only deficiency of both
adaptor proteins results in abrogated priming (Bauernfeind
et al., 2009). Interestingly, cytokines including TNF-a, IL-1a,
and IL-1b have been suggested to be capable to provide this
priming signal for NLRP3 assembly, providing an alternative
mechanism for inflammasome activation in ‘‘sterile inflamma-
tion’’ in the absence of microbial interactions (Franchi et al.,
2009a). In vivo, some of the NLRP3 activators can induce inflam-
masome formation in the absence of a priming signal. Whether
such signal is provided constitutively in the in vivo setting
remains to be determined.
The precise mechanismwhereby NLRP3 senses the presence
of its activators remains elusive. Although physical interaction of
microbial activators with NLRP3 may occur in some cases
(Marina-Garcı´a et al., 2008), a more general mechanism is
thought to involve a cellular mediator(s) that interacts with the
structurally diverse DAMPs and PAMPs to provide signals for
NLRP3 inflammasome formation. Similar indirect innate trig-
gering systems have been described in plants, in which path-
ogen-induced alterations in endogenous proteins are sensed
by NLR-like R proteins that, in turn, trigger canonical resistance
mechanisms against these pathogens (Mackey et al., 2002).
Three nonexclusive models for indirect NLRP3 activation have
been proposed and were reviewed in (Schroder and Tschopp,
2010) (Figure 1). The first involves ATP-induced activation of
the nonselective cation channel P2X7, which in turn activates
the larger pore-forming Pannexin-1, leading to potassium efflux
and potentially cytoplasmic migration of PAMPs and DAMPs,Immunity 34, May 27, 2011 ª2011 Elsevier Inc. 671
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devoid of Pannexin-1 activity retain normal potassium efflux
despite failure to assemble the NLRP3 inflammasome. The
second model suggests that NLRP3 inflammasome formation
is triggered through production of ROS, e.g., following ‘‘frus-
trated’’ endocytosis, with NADPH oxidase suggested to be
central in this process. However, although chemical inhibition
of ROS synthesis or knockdown of NADPH oxidase subunits
result in diminished inflammasome formation, monocytes
derived from NADPH-oxidase-deficient patients feature normal
IL-1b production (Meissner et al., 2010a). Recently, an alternative
source for ROS was suggested to be functionally impaired mito-
chondria. Inhibition of key steps in the respiratory chain or abro-
gation of defective mitochondria clearance by autophagy or
mitophagy resulted in enhanced mitochondrial production of
ROS, leading to NLRP3 inflammasome activation (Zhou et al.,
2011). The third mechanism involves lysosomal destabilization
after phagocytosis, leading to cytoplasmic leakage of inflamma-
some activators such as cathepsin B. Interestingly, the pore-
forming toxin nigericin, which triggers theNLRP3 inflammasome,
promotes potassium efflux but may also promote lysosomal
leakage. Nonetheless, cathepsin B-deficientmice feature normal
NLRP3 inflammasome assembly, which could indicate that other
lysosomal proteases are involved in proteolytic activation of the
NLRP3 inflammasome. In summary, it remains unclear at this
point whether the different proposed models are mutually exclu-
sive or whether these pathways can interact at different levels
regulating this important multiprotein complex.
Microbial Activators of the NLRP3 Inflammasome
Mounting evidence implicates the NLRP3 inflammasome as an
important molecular pathway mediating the response against
amyriad of pathogenicmicrobial infections. Although the precise
mechanisms of microbial sensing remain elusive, it is becoming
clear that many of the pathogens induce the formation of the
NLRP3 inflammasome through conserved pathways. At some
instances, activation of the NLRP3 inflammasome results in the
potentiation of the host antimicrobial response, while in others
it initiates pathogen-derived immune evasive mechanisms.
Bacterial Activators of the NLRP3 Inflammasome
Multiple bacterial pathogens were shown to activate the NLRP3
inflammasome. One common bacterial-mediated NLRP3 inflam-
masome-inducing mechanism involves secretion of pore-form-
ing toxins that promote potassium efflux and resultant NLRP3
inflammasome formation. One such example is the Gram-
positive rod L. monocytogenes in which NLRP3-dependent
inflammasome activation depends on the pore-forming toxin lis-
teriolysin (Mariathasan et al., 2006). Nlrp3/ mice have an
impaired immune response manifesting as delayed clearance of
L. monocytogenes. Interestingly, clearance is unaltered during
secondary infection of caspase-1-deficient mice, suggesting
that other host-derived anti microbial mechanisms bypass the
need for NLRP3 inflammasome sensing upon repeated infec-
tion (Tsuji et al., 2004). Likewise, secretion of Pneumolysin by
Streptococcus pneumoniae or Streptolysin O by Streptococcus
pyogenes induces NLRP3 inflammasome activation through
both potassium efflux and lysosomal leakage induction, whereas
Nlrp3/micedisplay impairedPneumococcal clearance (Harder672 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.et al., 2009;McNeela et al., 2010).Staphylococcus aureusNLRP3
activation is mediated by secretion of one of several toxins
(Craven et al., 2009; Mariathasan et al., 2006). Of these, a-hemo-
lysin acts independent of TLR signaling butmay require cosignal-
ing by bacterial-released lipoproteins (Mun˜oz-Planillo et al.,
2009). Interestingly, differences in responsiveness toa-hemolysin
activation of the NLRP3 inflammasome were found between
human andmouse cells, hinting toward species and cell-specific
differences in the inflammasome-related host response (Craven
et al., 2009).
Another mechanism of NLRP3 inflammasome activation is
employed by Mycobacteria. Infection of mice with Mycobacte-
rium marinum requires a functioning Esx-1 (type VII) secretion
system that induced IL-1b secretion through formation of
a NLRP3 inflammasome. Both Nlrp3/ and Asc/ mice had
attenuated disease compared to WT mice but an equal bacterial
burden, suggesting that IL-1b may have a detrimental effect for
the host in mycobacterium infection (Carlsson et al., 2010). Simi-
larly inMycobacterium tuberculosis, the Esx-1 secretion system
was found to contribute to bacterial virulence through the activity
of its substrate ESAT-6 that induced macrophage membrane
disruption, enabling cytoplasmic translocation of PAMPs that,
in turn, induced NLRP3 inflammasome activation (Mishra et al.,
2010).
Finally, intracellular bacteria may activate the NLRP3 inflam-
masome directly, through cytoplasmic release of bacterial-
derived molecules (enabling signal I) and concomitant activation
of host-derived inflammasome activation pathways. One such
example is the intracellular pathogen Chlamydia trachomatis,
whose growth was enhanced in a cervical epithelial cell line, by
the activation of the NLRP3 inflammasome in a type III secretion
system-dependent manner through induction of potassium
efflux and ROS production. Inflammasome-mediated pathogen
growth in this study was mediated by unknown IL-1b-indepen-
dent mechanisms. Nevertheless, the in vivo correlate of this
observation remains to be determined (Abdul-Sater et al., 2009).
A NLRP3 and ASC-mediated host response to bacterial infec-
tions that does not require caspase-1 was recently discovered. It
involves induction of necrosis of bacterially infected myeloid
cells and was coined pyronecrosis to distinguish it from pyropto-
sis, which requires caspase-1. Examples of pathogens sug-
gested to employ this mechanism include S. aureus, S. flexneri,
K. pneumonia, Porphyromonas gingivalis, and Neisseria gonor-
rhoeae (Craven et al., 2009; Duncan et al., 2009; Huang et al.,
2009; Willingham et al., 2009; Willingham et al., 2007). In these
infections, monocyte pyronecrosis was shown to be induced
by cytoplasmic leakage of cathepsin-B and to result in the
release of the proinflammatory factor HMGB1 from necrotic
cells. In vivo, Nlrp3/ mice infected with K. pneumonia were
characterized by attenuated lung inflammation, but diminished
survival, suggesting a role for pyronecrosis and the ensuing
inflammation in host protection against this infection.
Viral Activators of the NLRP3 Inflammasome
NLRP3 has been shown to be activated by viral ssRNA and
dsRNA and to play a major modulatory role in several viral infec-
tions like influenza and sendai viruses (Allen et al., 2009; Kanne-
ganti et al., 2006). Influenza virus is a potent inducer of IL-1b
secretion by macrophages and dendritic cells (Allen et al.,
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2009). In Nlrp3/ mice inoculated with influenza A, survival
during viral infection was shown to be impaired. It is unclear
whether this effect stems from defective clearance of the virus,
delayed pulmonary epithelial repair, or a combination of the
two. During influenza infection, transcriptional activation of the
inflammasome components (signal I) was found to depend on
viral RNA recognized through TLR7, whereas inflammasome
activation (signal II) was mediated by the M2 ionic channel,
through pH neutralization of the trans golgi network (TGN) that
results in potassium efflux and ROS production (Figure 2)
(Ichinohe et al., 2010). Importantly, the exact role of the NLRP3
inflammasome in modulation of antiviral adaptive immune
response remains controversial. A recent study suggests that
defined communities within the intestinal microbiota are required
for NLRP3 function during influenza infection. Bacterial signals
provide a constitutive ‘‘signal I’’ necessary for baseline expres-
sion of NLRP3 inflammasome components, enabling DC migra-
tion and resultant adaptive immune activation upon sensing of
influenza infection by the NLRP3 inflammasome. Impaired base-
line expression of inflammasomecomponents as a consequence
of oral antibiotic treatment was overcome by intestinal or pulmo-
nary administration of TLR agonists, possibly providing the
missing signal I (Figure 2) (Ichinohe et al., 2011). Detailed review
of inflammasome regulation of influenza infection is given else-
where (Pang and Iwasaki, 2011). Other viruses, such as the
DNA viruses vaccinia (Delaloye et al., 2009), adenovirus (Barlan
et al., 2011), and varicella zoster (Nour et al., 2011) and the
RNA viruses encephalomyocarditis virus and vesicular stomatitis
virus (Rajan et al., 2011) have been demonstrated to activate the
NLRP3 inflammasome, yet in vivo infection of caspase-1-defi-
cient mice with the later two viruses did not result in impaired
survival. The physiological importance of these observations
remains to be determined.
Fungal Activators of the NLRP3 Inflammasome
Several studies have recently shown that the NLRP3 inflamma-
some is essential for systemic antifungal immune response
against Candida albicans and Saccharomyces cerevisiae (Gross
et al., 2009; Hise et al., 2009; Kumar et al., 2009). In one study
(Hise et al., 2009), the Candida PAMPs b-glucan and zymosan,
which bind Dectin-1 and TLR2 respectively, were shown to
induce pro-IL-1b transcriptional activation (signal I), whereas
a yet uncharacterized Candida-derived molecule induced
assembly of the NLRP3 inflammasome (signal II). Interestingly,
inactivated immature hyphal forms were also able to induce
this assembly. In another study (Gross et al., 2009), C. albicans
was shown to specifically activate the NLRP3 inflammasome
by signaling through Syk, which functions downstreamof several
PRR including Dectin-1. Syk was found to regulate both produc-
tion of pro-IL-1b (signal I) and inflammasome formation (signal II),
by inducing potassium efflux and production of ROS. Nlrp3/
mice featured an impaired containment of C. albicans, mani-
fested as widespread fungal dissemination leading to enhanced
mortality. Interestingly, fungal b-glucan-induced humoral
response was also found to be dependent upon NLRP3 (Kumar
et al., 2009). Coupling Syk to inflammasome signaling may link
the NLRP3 inflammasome pathway to other Syk-dependent
pathways such as those downstreamof C-type Lectin Receptorsthat also function as PRR (Kumar et al., 2009; Robinson et al.,
2006). In vitro, Aspergillus fumigatus is similarly capable of acti-
vating the NLRP3 inflammasome, although it remains unknown
whether NLRP3 is also required in vivo to limit infection (Saı¨d-
Sadier et al., 2010).
Parasitic Activators of the NLRP3 Inflammasome
The role of NLRP3 in parasitic infections is just beginning to be
revealed. The plasmodium-secreted crystal hemozoin was
recently shown to induce IL-1b secretion through activation of
the NLRP3 inflammasome via Syk and Lyn kinase-dependent
mechanisms. In vivo, malaria severity was found to be attenu-
ated in Nlrp3/ mice (Dostert et al., 2009; Shio et al., 2009).
Similarly in another study, Nlrp3/mice featured delayed onset
of cerebral malaria, yet this phenotype was not observed in mice
deficient of caspase-1, ASC, and IL-1 receptor, suggesting that
this NLRP3-induced effect was not mediated by formation of an
inflammasome (Reimer et al., 2010). Even less is known about
possible inflammasome-related roles in helminthic infection.
Schistosomal egg antigens activate the NLRP3 inflammasome
(Ritter et al., 2010). This effect was dependent on the PRR
dectin-2, as well as on potassium efflux, ROS production, and
Syk activity. In vivo, Schistosoma-infected Nlrp3/ and Asc/
mice featured an aberrant adaptive immune response, manifest-
ing reduced IL-17A, IFN-g, IL-5, and IL-10 levels, elevated IL-13
levels, and reduced hepatic granuloma formation.
NLRP1
Although the NLRP3 inflammasome has been the main focus of
many research groups, the NLRP1 inflammasome was the first
to be described (Martinon et al., 2002). NLRP1 is expressed in
multiple cell types including granulocytes, monocytes, dendritic
cells, T and B cells, neurons, and testes. In humans, a single
gene encodes NLRP1 that contains a PYD, a NBD, a LRR,
a FIIND, and a C-terminal CARD. In mice, three highly polymor-
phic paralogues (Nlrp1a, Nlrp1b, and Nlrp1c) have been
described (Franchi et al., 2009b). Unlike human NLRP1, murine
NLRP1 lacks functional PYD and FIIND domains and is predicted
to not be able to interact with ASC. Indeed, NLRP1b has been
shown to activate caspase-1 in an ASC-independent manner
(Hsu et al., 2008).
Genetic studies identified the Nlrp1b gene as the key determi-
nant of susceptibility to Bacillus anthracis lethal toxin (LeTx) in
mice (Boyden and Dietrich, 2006). Subsequently, it was revealed
that LeTx-induced macrophage cell death is dependent on
caspase-1 activation by the Nlrp1b-sensitive allele (Boyden
and Dietrich, 2006; Hsu et al., 2008). However, the mechanism
of LeTx activation of the NLRP1 inflammasome remains to be
determined. As is the case for the NLRP3 inflammasome
(Marina-Garcı´a et al., 2008), NLRP1 can also be activated by
MDP. MDP was suggested to induce conformational changes
in NLRP1, which enable its oligomerization, thus creating a plat-
form for caspase-1 activation (Faustin et al., 2007). In addition,
recent studies indicate that NLRP1 and NOD2 interaction is
required for proper responses to LeTx and MDP in vivo. NOD2
promotes pro-IL-1b (signal I) transcription in an NF-kB-depen-
dent manner and it regulates caspase-1 activation by MDP
through direct interaction with NLRP1 (Hsu et al., 2008). Further
studies are required to determine the physiological relevance ofImmunity 34, May 27, 2011 ª2011 Elsevier Inc. 673
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the NLRP1 and NLRP3 inflammasomes during host responses
to MDP.
The importance of the NLRP1 inflammasome during host
responses is highlighted by the existence of host and microbial
inhibitors to its assembly and function. The antiapoptotic
proteins Bcl-2 and Bcl-X(L) bind and suppress NLRP1, reducing
caspase-1 activation and IL-1b production (Bruey et al., 2007).
CD4+ effector and memory T cells suppress NLRP1 and
NLRP3-inflammasome activation through TNF family ligands in
a cell contact-dependent manner (Guarda et al., 2009). Similarly,
type I interferons inhibit Nlrp1b and NLRP3 inflammasome-
dependent caspase-1 activation through a yet to be determined
STAT-1-mediated mechanism (Guarda et al., 2011). Finally,
Kaposi sarcoma herpes virus Orf63 is a viral homolog of human
NLRP1 that interacts with NLRP1, NLRP3, and NOD2. Orf63
blocks NLRP1-dependent innate immune responses and is
required for reactivation and generation of progeny virus (Greg-
ory et al., 2011).
Other NLR Proteins in Antimicrobial Responses
Multiple other NLR proteins have been identified in humans and
mice, yet with a few exceptions their functions, including the host
antimicrobial response, are currently unknown. The role of CIITA
in regulating MHC class II expression has been reviewed else-
where (Wright and Ting, 2006). NLRP2, NLRP6, and NLRP12
have been proposed to activate caspase-1 through inflamma-
some assembly and to negatively regulate proinflammatory
signaling pathways (Bruey et al., 2004; Grenier et al., 2002;
Wang et al., 2002). Interestingly, NLRP2 mediates the induction
of human beta defensins (HBD) by Fusubacterium nucleatum in
gingival epithelial cells, suggesting that it may be involved in
regulation of microbial communities in the oral cavity (Ji et al.,
2009). NLRP12 has been suggested to possess anti-inflamma-
tory regulatory properties, potentially through modulation of
IRAK1 phosphorylation, and during infection its levels drop
sharply, enhancing TLR signaling (Williams et al., 2005). Interest-
ingly, Nlrp12/ mice were shown to exhibit attenuated inflam-
matory responses in two models of contact hypersensitivity
because of reduced dendritic cell migration (Arthur et al.,
2010). This mechanism could also potentially affect the antimi-
crobial host response.
NLRC5 is a highly conserved member of the same subfamily
as the NOD proteins. It contains a large LRR region, a central
NOD domain, and a C-terminal CARD-like domain (Schroder
and Tschopp, 2010). The role of NLRC5 as a modulator of the
inflammatory immune response remains unclear and controver-
sial. Earlier studies showed that NLRC5 inhibits NF-kB and type I
interferon pathways through interaction with IKKa and b and
RIG-I and MDA5, respectively (Cui et al., 2010). Accordingly,
knockdown of NLRC5 resulted in enhanced antiviral immunity
(Cui et al., 2010). Benko et al. (2010) also demonstrated that
NLRC5 limits activation of proinflammatory pathways via tran-
scriptional repression. In contrast to these studies, two groups
reported that NLRC5 potentiates antiviral responses (Kuenzel
et al., 2010; Neerincx et al., 2010); moreover, macrophages
from Nlrc5/ mice stimulated ex vivo-induced normal levels of
IFN-b, IL-6, and TNF-a after treatment with RNA viruses, DNA
viruses, and bacteria (Kumar et al., 2011). These results indicate674 Immunity 34, May 27, 2011 ª2011 Elsevier Inc.that NLRC5 may be dispensable for cytokine induction during
viral infections under physiological conditions. Finally, two inde-
pendent studies demonstrated that NLRC5 regulates processing
of IL-1b upon overexpression or in response to NLRP3 inflamma-
some-activating molecular patterns (Kumar et al., 2011) and that
NLRC5 physically interacts with NLRP3 (Davis et al., 2011).
These results invoke the possibility that NLRC5 might cooperate
with NLRP3 to activate the NLRP3 inflammasome. Interestingly,
NLRC5 has been shown to be a transcriptional regulator of MHC
class I genes, supporting the observation that NLRC5 is most
similar to CIITA (Meissner et al., 2010b).
NLRX1 is a member of the NLR family that contains an N
terminus CARD-related ‘‘X’’ domain. NLRX1 is targeted to the
mitochondria matrix where it has been shown to interact with
MAVS and modulate antiviral responses (Arnoult et al., 2009;
Moore et al., 2008). Moreover, NLRX1 can also potentiate proin-
flammatory signaling pathways by inducing reactive oxygen
species (ROS) in HeLa cells (Tattoli et al., 2008), which in turn
impacts the growth of the intracellular bacteria Chlamydia
trachomatis (Abdul-Sater et al., 2010). Analysis of mice deficient
for NLRX1 is required to elucidate the role of this NLR in the regu-
lation of host anti-microbial immune responses.
Finally, emerging evidence suggests that non-NLR innate
receptors may cooperate with NLR proteins and with other in-
flammasome adaptors in microbial sensing. One such example
is the non-NLR protein AIM2, which was recently shown to
form an ASC-dependent inflammasome and to recognize
dsDNA and was also shown to play a central role in cytosolic
sensing of bacteria and DNA viruses, including Fransicella tular-
ensis, vaccinia virus, mouse cytomegalovirus (MCMV), and to
a certain extent L. monocytogenes (Fernandes-Alnemri et al.,
2010; Jones et al., 2010; Rathinam et al., 2010). Another example
is the viral nucleic acid recognition receptor RIG-I, which was
recently shown to bind ASC and activate caspase-1 in response
to viral infection, resulting in IL-1b production, a process that is
independent of NLRP3 (Poeck et al., 2010). Altogether, these
data suggest that cytosolic pathogen sensing may involve
complex interactions, in which the NLR family members and in-
flammasome adaptors may actively interact with sensors and
adaptors of other pathways, depending on the infectious
context.
NLR Mutations in Human Infectious Disease
In recent years, multiple members of the NLR family have been
associated with human disease (reviewed in Hoffman and
Brydges, 2011). Examples includemonogenic auto-inflammatory
disorders such as Muckle–Wells syndrome (MWS), familial cold
auto-inflammatory syndrome (FCAS), and chronic infantile neuro-
logical cutaneous and articular syndrome (CINCA), which are
associated with NLRP3 gain-of-function mutations, whereas
Blau syndrome is associated with NOD2 gain-of-function muta-
tions (Borzutzky et al., 2010). The most well established NLR link
to a multifactorial autoinflammatory disorder is the association
between mutations in NOD2 and Crohn’s disease, which occur
in 30% of patients of European ancestry as compared to %1%
in unaffected individuals (Cho, 2008). A number of aberrations
have been found in patient immune cells including impaired cyto-
kine secretion, reduced Paneth cell antimicrobial peptide pro-
duction, diminished IL-10 secretion after microbial stimulation,
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analysis revealed that mutations within the NLRP3 locus are
also strongly associated with risk factors for the development of
Crohn’sdisease (Villani et al., 2009). Sporadic reportsonsuccess-
ful IL-1 receptor antagonist (Anakinra) treatment in patients with
intractable gout (Abdul-Sater et al., 2009) and pseudogout (sug-
gested inmice tobe regulatedby theNLRP3 inflammasome)point
to the possibility that human gout, and possibly other crystal
deposition diseases, are also NLRP3 regulated (McGonagle
et al., 2007). Similarly, mutations in NLRP1 are associated with
some cases of vitiligo andAddison’s disease (Jin et al., 2007; Zur-
awek et al., 2010).
Less studied are the possible associations between NLR
mutations and the propensity for infection. Mutations in the
NOD2 gene were recently suggested to be associated with an
increased risk for thedevelopment of spontaneousbacterial peri-
tonitis (SBP) in cirrhotic patients with ascites, possibly linking
NOD2’s effects on the intestinal barrier function to enhanced
bacterial translocation in susceptible patient populations (Ap-
penrodt et al., 2010; Nischalke et al., 2011). A recent genome-
wide association analysis revealed that single-nucleotide poly-
morphisms (SNPs) related to several genes in theNOD2signaling
pathway were significantly associated with leprosy. This raised
the possibility that Crohn’s disease and multibacillary leprosy,
both of which involve granuloma formation possibly driven by
aberrant Th1 responses, share underlying NOD2 pathway aber-
rations (Berrington et al., 2010b; Zhang et al., 2009).
Future studies in human patients may unravel roles of these
and other NLR proteins, through the mechanisms discussed in
this review in other multifactorial diseases, including infectious
diseases. Studying their mechanisms of action will be of signifi-
cant clinical importance and may enable the development of
novel therapeutic interventions for these disorders.
Concluding Remarks
NLRs are central mediators of microbial sensing. In most cases,
NLR-mediated pathogen recognition is employed by the host as
part of the antimicrobial immune response. In aminority of cases,
this sensing is manipulated by pathogens as part of immune-
evasive mechanisms. However, many important open questions
remain. These include how microbial signals are sensed by the
different NLRs, how different NLRs interact with each other
and with other host signaling pathways, how NLR binding and
activation leads to initiation of the anti-microbial response, how
NLRs modulate the adaptive anti-microbial immune response,
and what is the clinical significance of aberrations in NLR
signaling with respect to host vulnerability to infection. Decipher-
ing these mechanisms will undoubtedly enable further under-
standing of the innate immune response against pathogens.
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